Bladder cancer

CYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study

Y. L. Song, Wang, L., Ren, J. C., Xu, Z. H., Song, Y. L., Wang, L., Ren, J. C., Xu, Z. H., Song, Y. L., Wang, L., Ren, J. C., and Xu, Z. H., CYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study, vol. 15, p. -, 2016.

To date, no study has investigated the association between CYP1A2-163C/A polymorphism and bladder cancer risk in a Chinese population. Here, we extracted genomic DNA from peripheral white blood cells, and differentiated CYP1A2 alleles by polymerase chain reaction-based restriction fragment length polymorphism methods. Differences in genotype frequencies between the cases and controls were evaluated using a chi-square test. The odds ratio (OR) and its 95% confidence interval (CI) were calculated using an unconditional logistic regression model.

Subscribe to Bladder cancer